Skip to main content

Dr Paul Zeun

Dr Zeun is a consultant neurologist with a subspecialist interest in movement disorders such as Parkinson’s disease and Huntington’s disease.

BMBS, PhD

Training and education

Dr Zeun trained at Brighton and Sussex medical school where he obtained a BSc in pharmacological sciences.

After completing foundation programme in Norwich he then gained his first neurology experience at Charing Cross Hospital as a senior house officer, before completing his neurology training in the Wessex deanery at Southampton and Portsmouth hospitals.

He also completed a PhD during this time at UCL Queen Square Institute of Neurology in the Huntington’s disease department, under the supervision of Professor Sarah Tabrizi. Dr Zeun's focus was identifying the earliest signs and markers of neurodegeneration in Huntington’s disease gene carriers and he also worked as a sub-investigator on the Roche Tominersen Huntington lowering clinical trial in that time.

Experience

Dr Zeun has two weekly clinics at Queen Alexandra hospital in Portsmouth where he sees a range of conditions including headaches, epilepsy, people with memory complaints, multiple sclerosis among others. He also runs the specialist Parkinson’s clinic.

At Southampton General Hospital he runs the botulinum toxin service for cervical dystonia and hemifacial and blepharospasm and has a monthly movement disorders clinic.

Awards and prizes

  • 2nd Prize in the registrar case presentations competition at the South East of England Neurologists association autumn meeting 2022
  • Queen Square Prize Winner: Prize for best essay detailing original research at the National Hospital for Neurology and Neurosurgery (Queen Square). 2020
  • Deans prize for best contribution to student body and university life. 2011

Research

  • Zeun P, McColgan P, Dhollander T et al. Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease. Neuroimage Clin. 2022;33:102927
  • Scahill RI, Zeun P, Osborne-Crowley K et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington’s disease young adult study (HD-YAS): a cross-sectional analysis. Lancet Neurol. 2020 Jun;19(6):502-512
  • Zeun P, Scahill RI, Tabrizi SJ, Wild EJ. Fluid and imaging biomarkers for Huntington’s disease. Mol Cell Neurosci. 2019 Jun;97:67-80

Contact

You can contact Dr Zeun via his secretary, Debbie Firman - call 023 8120 2608 or send an email.